Skip to main content
NCBI home page
British Journal of Pharmacology and Chemotherapy logoLink to British Journal of Pharmacology and Chemotherapy
. 1964 Feb;22(1):56–65. doi: 10.1111/j.1476-5381.1964.tb01543.x

Actions of mecamylamine, dimecamine, pempidine and their two quaternary metho-salts at the neuromuscular junction

J G Blackman, C Ray
PMCID: PMC1703911  PMID: 14126057

Abstract

Mecamylamine, dimecamine and pempidine differed in neuromuscular-blocking activity on the isolated phrenic nerve-diaphragm preparation of the rat from the corresponding methiodides by a factor of less than two. It was concluded that the active component of each amine was the cation acting extracellularly. The finding that the neuromuscular-blocking activity of mecamylamine at pH 6.7 was similar to the activity at pH 7.7 did not refute this conclusion. Mecamylamine, dimecamine methiodide, dimecamine and pempidine, at concentrations insufficient to cause block, could increase the twitch response of the rat diaphragm; the ability to do this increased in the above order. With pempidine (the most active compound) this effect, on the isolated sartorius muscle of the frog, was a direct action. During steady partial block by each of the compounds, the responses to brief tetanic stimulation, to neostigmine and to an increase in calcium concentration were similar to those observed during block by tubocurarine. From indirect evidence, pempidine methiodide appeared both to enhance the release of acetylcholine from motor-nerve terminals and to cause postsynaptic block.

Full text

PDF
56

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BENNETT G., TYLER C., ZAIMIS E. Mecamylamine and its mode of action. Lancet. 1957 Aug 3;273(6988):218–222. doi: 10.1016/s0140-6736(57)91598-2. [DOI] [PubMed] [Google Scholar]
  2. BLACKMAN J. G. Stimulus frequency and neuromuscular block. Br J Pharmacol Chemother. 1963 Feb;20:5–16. doi: 10.1111/j.1476-5381.1963.tb01292.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. CORNE S. J., EDGE N. D. Pharmacological properties of pempidine (1:2:2:6:6-pentamethylpiperidine), a new ganglion-blocking compound. Br J Pharmacol Chemother. 1958 Sep;13(3):339–349. doi: 10.1111/j.1476-5381.1958.tb00915.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. CREESE R. Bicarbonate ion and striated muscle. J Physiol. 1949 Dec;110(3-4):450–457. doi: 10.1113/jphysiol.1949.sp004452. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. DEL CASTILLO J., NELSON T. E., Jr, SANCHEZ V. Mechanism of the increased acetylcholine sensitivity of skeletal muscle in low pH solutions. J Cell Comp Physiol. 1962 Feb;59:35–44. doi: 10.1002/jcp.1030590105. [DOI] [PubMed] [Google Scholar]
  6. FURSHPAN E. J., POTTER D. D. Transmission at the giant motor synapses of the crayfish. J Physiol. 1959 Mar 3;145(2):289–325. doi: 10.1113/jphysiol.1959.sp006143. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. GINSBORG B. L., WARRINER J. The isolated chick biventer cervicis nerve-muscle preparation. Br J Pharmacol Chemother. 1960 Sep;15:410–411. doi: 10.1111/j.1476-5381.1960.tb01264.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. GORE M. B. R. Adenosinetriphosphatase activity of brain. Biochem J. 1951 Nov;50(1):18–24. doi: 10.1042/bj0500018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. HARINGTON M., KINCAID-SMITH P., MILNE M. D. Pharmacology and clinical use of pempidine in the treatment of hypertension. Lancet. 1958 Jul 5;2(7036):6–11. doi: 10.1016/s0140-6736(58)90002-3. [DOI] [PubMed] [Google Scholar]
  10. HARRIS E. J. The exchange of frog muscle potassium. J Physiol. 1953 Apr 28;120(1-2):246–253. doi: 10.1113/jphysiol.1953.sp004889. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. KALOW W. The influence of pH on the ionization and biological activity of d-tubocurarine. J Pharmacol Exp Ther. 1954 Apr;110(4):433–442. [PubMed] [Google Scholar]
  12. MILNE M. D., ROWE G. G., SOMERS K., MUEHRCKE R. C., CRAWFORD M. A. Observations on the pharmacology of mecamylamine. Clin Sci. 1957 Nov;16(4):599–614. [PubMed] [Google Scholar]
  13. MUGGLETON D. F., READING H. W. Absorption, metabolism and elimination of pempidine in the rat. Br J Pharmacol Chemother. 1959 Jun;14(2):202–208. doi: 10.1111/j.1476-5381.1959.tb01384.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. PAYNE J. P., ROWE G. G. The effects of mecamylamine in the cat as modified by the administration of carbon dioxide. Br J Pharmacol Chemother. 1957 Dec;12(4):457–460. doi: 10.1111/j.1476-5381.1957.tb00165.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. PAYNE J. P. The influence of mecamylamine on the action of certain other ganglionic blocking agents. Br J Anaesth. 1957 Aug;29(8):358–362. doi: 10.1093/bja/29.8.358. [DOI] [PubMed] [Google Scholar]
  16. SPINKS A., YOUNG E. H., FARRINGTON J. A., DUNLOP D. The pharmacological actions of pempidine and its ethyl homologue. Br J Pharmacol Chemother. 1958 Dec;13(4):501–520. doi: 10.1111/j.1476-5381.1958.tb00246.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. STONE C. A., TORCHIANA M. L., NAVARRO A., BEYER K. H. Ganglionic blocking properties of 3-methylaminoisocamphane hydrochloride (mecamylamine): a secondary amine. J Pharmacol Exp Ther. 1956 Jun;117(2):169–183. [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology and Chemotherapy are provided here courtesy of The British Pharmacological Society

RESOURCES